Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.

PURPOSE An accurate, intraoperative sentinel lymph node (SLN) test could decrease delayed axillary dissections. Molecular tests may be more sensitive than current intraoperative tests but historically have not been rapid enough and have not been properly validated. We present the results from a large, prospective evaluation of the first rapid molecular SLN test, the Breast Lymph Node (BLN) Assay. METHODS A beta trial (n = 304) to determine the threshold levels of mammaglobin and cytokeratin 19 correlating with metastasis greater than 0.2 mm and a validation trial (n = 416) to validate the threshold cutoffs were conducted. Alternating portions from each SLN were processed for histology and the BLN Assay. RESULTS BLN Assay performance against extensive permanent-section histology verified by central pathology review was similar to that expected of standard permanent-section histology: sensitivity, 87.6%; specificity, 94.2%; positive predictive value, 86.2%; and negative predictive value (NPV), 94.9%. In 319 patients with both frozen-section hematoxylin and eosin results and BLN Assay results, the BLN Assay had higher sensitivity (95.6%) and NPV (98.2%) than frozen section (sensitivity, 85.6%; NPV, 94.5%). The assay can be performed in approximately 36 to 46 minutes for one to three nodes. CONCLUSION The BLN Assay allows a rapid evaluation of 50% of each SLN. Comparison with permanent-section histology on adjacent node pieces evaluated by expert pathologists indicated that the BLN Assay was more sensitive than current intraoperative techniques while maintaining high specificity. These data indicate that the assay may be clinically useful for intraoperative or postoperative axillary lymph node dissection decisions.

[1]  M. Christiaens,et al.  Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment , 2005, Current opinion in oncology.

[2]  V. Speights,et al.  Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. , 2003, Archives of pathology & laboratory medicine.

[3]  Morton Dl.  Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? , 1997 .

[4]  S. Reed,et al.  Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. , 2002, Clinical chemistry.

[5]  P. Schlag,et al.  Long‐term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection , 2006, Journal of surgical oncology.

[6]  J. Peterse,et al.  Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.

[7]  S. Jaffer,et al.  Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Wilke,et al.  Update on the NSABP and ACOSOG Breast Cancer Sentinel Node Trials , 2004, The American surgeon.

[9]  D. Krag,et al.  Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer , 1998, Annals of Surgical Oncology.

[10]  H. Koyama,et al.  Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer , 2002, The British journal of surgery.

[11]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[12]  G. Lindberg,et al.  Interpretive disparity among pathologists in breast sentinel lymph node evaluation. , 2003, American journal of surgery.

[13]  Andreas Shamiyeh,et al.  Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.

[14]  J. E. Boers,et al.  Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications , 2007, Breast Cancer Research and Treatment.

[15]  Yixin Wang,et al.  Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. , 2005, The Journal of molecular diagnostics : JMD.

[16]  A. Giuliano,et al.  Intraoperative examination of the sentinel lymph node for breast carcinoma staging. , 1999, American journal of clinical pathology.